Jeffrey Garro
Stock Analyst at Stephens
(0.06)
# 4,627
Out of 4,655 analysts
73
Total ratings
31.3%
Success rate
-22.7%
Average return
Main Sectors:
Stocks Rated by Jeffrey Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Rated: Hold | $10 → $7 | $8.72 | -19.72% | 6 | May 13, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | $2 → $1.75 | $1.85 | -5.41% | 5 | May 12, 2026 | |
| CERT Certara | Maintained: Buy | $12 → $9 | $8.00 | +12.50% | 6 | May 12, 2026 | |
| PHR Phreesia | Maintained: Buy | $37 → $20 | $12.28 | +62.87% | 3 | Mar 31, 2026 | |
| DH Definitive Healthcare | Maintained: Hold | $5 → $3 | $0.6392 | +369.34% | 2 | Feb 27, 2026 | |
| EVH Evolent Health | Maintained: Buy | $7 | $4.68 | +49.57% | 4 | Feb 25, 2026 | |
| SLP Simulations Plus | Maintained: Buy | $28 → $20 | $18.35 | n/a | 3 | Jul 15, 2025 | |
| TDOC Teladoc Health | Maintained: Hold | $8 | $6.81 | n/a | 1 | Apr 30, 2025 | |
| PRVA Privia Health Group | Maintained: Buy | $26 → $30 | $22.00 | n/a | 3 | Mar 5, 2025 | |
| MDRX Veradigm Inc. | Maintained: Hold | $13 → $7 | $4.90 | n/a | 9 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $255 → $250 | $236.66 | n/a | 3 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $243.75 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $55 | $24.80 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $13.96 | n/a | 5 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $5 → $3.9 | $10.61 | n/a | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $0.7288 | n/a | 7 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $150.52 | n/a | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 5 | May 6, 2020 |
OptimizeRx
May 13, 2026
Rated: Hold
Price Target: $10 → $7
Current: $8.72
Upside: -19.72%
Health Catalyst
May 12, 2026
Maintained: Hold
Price Target: $2 → $1.75
Current: $1.85
Upside: -5.41%
Certara
May 12, 2026
Maintained: Buy
Price Target: $12 → $9
Current: $8.00
Upside: +12.50%
Phreesia
Mar 31, 2026
Maintained: Buy
Price Target: $37 → $20
Current: $12.28
Upside: +62.87%
Definitive Healthcare
Feb 27, 2026
Maintained: Hold
Price Target: $5 → $3
Current: $0.6392
Upside: +369.34%
Evolent Health
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $4.68
Upside: +49.57%
Simulations Plus
Jul 15, 2025
Maintained: Buy
Price Target: $28 → $20
Current: $18.35
Upside: n/a
Teladoc Health
Apr 30, 2025
Maintained: Hold
Price Target: $8
Current: $6.81
Upside: n/a
Privia Health Group
Mar 5, 2025
Maintained: Buy
Price Target: $26 → $30
Current: $22.00
Upside: n/a
Veradigm Inc.
Jan 31, 2025
Maintained: Hold
Price Target: $13 → $7
Current: $4.90
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $255 → $250
Current: $236.66
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $280
Current: $243.75
Upside: n/a
Dec 19, 2024
Initiated Coverage: Hold
Price Target: $55
Current: $24.80
Upside: n/a
Aug 5, 2022
Maintained: Buy
Price Target: $15 → $20
Current: $13.96
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $5 → $3.9
Current: $10.61
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $4 → $3
Current: $0.7288
Upside: n/a
Dec 20, 2021
Maintained: Buy
Price Target: n/a
Current: $150.52
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a